ACADIA Pharmaceuticals Inc.
US ˙ NasdaqGS ˙ US0042251084

SecurityACAD / ACADIA Pharmaceuticals Inc.
InstitutionTruist Financial Corp
Latest Disclosed Ownership26,453 shares
Latest Disclosed Value $ 588,844
Truist Financial Corp reports 11.33% decrease in ownership of ACAD / ACADIA Pharmaceuticals Inc.

On April 27, 2026 - Truist Financial Corp filed a 13F-HR form disclosing ownership of 26,453 shares of ACADIA Pharmaceuticals Inc. (US:ACAD) valued at $588,844 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 29,834 shares of ACADIA Pharmaceuticals Inc.. This represents a change in shares of -11.33% during the quarter. The current value of the position is $566,888 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 26,453 -3,381 -11.33 589 -26.13 0.0008
2026-02-02 2025-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 29,834 4,057 15.74 797 44.73 0.0011
2025-11-03 2025-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 25,777 -11,064 -30.03 550 -30.73 0.0007
2025-07-18 2025-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 36,841 -2,474 -6.29 795 21.59 0.0012
2025-04-29 2025-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 39,315 -10,303 -20.76 653 -28.24 0.0010
2025-01-31 2024-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 49,618 -4,965 -9.10 910 8.46 0.0014
2024-11-13 2024-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 54,583 4,577 9.15 839 3.33 0.0013
2024-08-21 2024-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 50,006 6,887 15.97 813 1.88 0.0012
2024-05-13 2024-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 43,119 -20,807 -32.55 797 -60.17 0.0012
2024-02-02 2023-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 63,926 -32,824 -33.93 2,002 -0.74 0.0032
2023-11-14 2023-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 96,750 32,068 49.58 2,016 30.15 0.0034
2023-08-01 2023-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 64,682 20,357 45.93 1,549 85.73 0.0026
2023-05-05 2023-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 44,325 6,539 17.31 834 38.77 0.0014
2023-02-17 2022-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 37,786 -4,082 -9.75 602 -12.26 0.0011
2022-10-26 2022-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 41,868 -7,513 -15.21 685 -1.58 0.0013
2022-07-22 2022-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 49,381 -12,016 -19.57 696 -53.19 0.0013
2022-04-22 2022-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 61,397 -20,861 -25.36 1,487 -22.55 0.0023
2022-02-14 2021-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 82,258 -21,742 -20.91 1,920 11.18 0.0029
2021-11-05 2021-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 104,000 16,973 19.50 1,727 -18.61 0.0028
2021-08-16 2021-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 87,027 11,390 15.06 2,122 8.76 0.0035
2021-05-17 2021-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 75,637 32,911 77.03 1,951 -14.58 0.0034
2021-11-19 2020-12-31 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 42,726 13,358 45.48 2,284 88.60 0.0044
2021-02-18 2020-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 46,724 17,356 2,498 0.0046
2021-11-05 2020-09-30 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 29,368 13,002 79.45 1,211 52.71 0.0026
2020-11-13 2020-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 29,368 13,002 1,211 0.0026
2021-11-16 2020-06-30 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 16,366 2,054 14.35 793 31.07 0.0018
2020-08-14 2020-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 16,366 2,054 793 0.0018
2021-11-05 2020-03-31 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 14,312 1,211 9.24 605 7.84 0.0016
2020-05-15 2020-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 14,312 1,211 605 0.0016
2021-11-16 2019-12-31 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 13,101 13,101 561 0.0011
2020-02-14 2019-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 13,101 13,101 561 0.0011
2018-01-29 2017-12-31 13F ACADIA COMMON STOCK 004225108 0 -5,836 -100.00 0 -100.00
2017-10-23 2017-09-30 13F ACADIA COMMON STOCK 004225108 5,836 5,836 220 0.0043
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.